FCN2 and acute myeloid leukemia: Consequently, high ficolin-2 levels (> 6.35 μg/ml) were overrepresented among AML patients (29.5%), in comparison with controls (5.2%) [p < 0.00001, OR = 7.65, 95% CI (3.92–14.57); after multiple logistic regression analysis: p < 0.001 OR = 5.43 95% CI (2.01–14.63)].